Director at Verrica (NASDAQ: VRCA) receives 16,000 stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Verrica Pharmaceuticals Inc. director Lawrence Eichenfield received a grant of stock options covering 16,000 shares of common stock. The options have an exercise price of $6.04 per share and expire on June 4, 2036.
These options vest in 12 equal monthly installments beginning on July 5, 2026 and are expected to be fully vested by the next annual meeting of stockholders, assuming he continues to serve as a director through each vesting date. Following this award, he holds 16,000 derivative securities directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Eichenfield Lawrence
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 16,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 16,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 16,000 options
Exercise price: $6.04 per share
Expiration date: June 4, 2036
+3 more
6 metrics
Option grant size
16,000 options
Stock Option (right to buy) granted to director
Exercise price
$6.04 per share
Exercise price of granted stock options
Expiration date
June 4, 2036
Option expiration for director grant
Underlying shares
16,000 shares
Common stock underlying the option grant
Vesting start
July 5, 2026
First vesting date, then 12 equal monthly installments
Post-grant derivative holdings
16,000 options
Total derivative securities held directly after transaction
Key Terms
Stock Option (right to buy), exercise price, expiration date, vest and become exercisable, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
exercise price financial
"conversion_or_exercise_price: "6.0400" per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-04T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vest and become exercisable financial
"shares underlying this option shall vest and become exercisable in 12 equal monthly installments"
annual meeting of stockholders financial
"fully vested on the date of the next annual meeting of stockholders"
FAQ
What did Verrica Pharmaceuticals (VRCA) disclose in this Form 4?
Verrica disclosed that director Lawrence Eichenfield received a grant of stock options for 16,000 shares at an exercise price of $6.04, expiring June 4, 2036, as part of his director compensation.
How many Verrica (VRCA) stock options were granted to Lawrence Eichenfield?
Lawrence Eichenfield was granted stock options for 16,000 shares of Verrica common stock. These options give him the right to buy shares at a fixed $6.04 exercise price, subject to the vesting schedule disclosed.
What is the exercise price and expiration date of the new VRCA options?
The granted Verrica options have an exercise price of $6.04 per share and an expiration date of June 4, 2036. This means they can be exercised at $6.04 any time after vesting until that expiration date.
When do Lawrence Eichenfield’s Verrica (VRCA) options vest?
The options begin vesting on July 5, 2026, in 12 equal monthly installments. They will be fully vested by the date of Verrica’s next annual stockholder meeting, assuming Eichenfield continues serving as a director through each vesting date.
Is this Verrica (VRCA) Form 4 a stock purchase or an option grant?
This Form 4 reflects an option grant, not an open-market stock purchase. Eichenfield received stock options to buy 16,000 shares at $6.04, which vest over time rather than immediate ownership of common shares.
How many Verrica derivative securities does Lawrence Eichenfield hold after this grant?
After this grant, Eichenfield holds 16,000 derivative securities in the form of stock options. These options represent the right to acquire 16,000 shares of Verrica common stock once they vest and are exercised at $6.04 per share.